Eloxx Pharmaceuticals, Inc.
ELOX
Last
$13.74
Day
-9.5%
1y
+37.9%
5y
+37.9%
52w
-35.1%
SPY YTD
+13.3%
XLV
+8.1%
Earnings
2026-11-1031d
EMA 21
15.73
EMA 50
15.72
EMA 200
13.50
20d high
-20.0%
5y high
-35.1%
5y range
46th
Positions held
Your positionsELOX isn't in your positions.
Add it to see shares, cost, and P&L here.
Score
17
Hold
watch
Signal
Neutral
Target
$19.08
Stop
$13.23
Stop distance
3.7%
Target vs last
+38.9%
Fundamentals
| Market cap | $61.27M | Enterprise value | $11.14M | Trailing P/E | 4.40 | Forward P/E | -21.38 |
| PEG | 1.85 | Price / book | 1.32 | Beta | -171,332.88 | Dividend yield | 0.00% |
| Revenue growth | — | Earnings growth | — | Gross margin | 0.0% | Operating margin | 0.0% |
| Profit margin | 0.0% | ROE | — | ROA | — | Debt / equity | 0.25 |
| Current ratio | 3.74 | Free cash flow | — | Analyst recommendation | none | Mean target | $38.25 |
| 52w high | $23.40 | 52w low | $8.20 |
Quarterly
| 2026-Q2 | 2026-Q1 | 2025-Q2 | 2025-Q1 | |
|---|---|---|---|---|
| Revenue | $0.0M | $0.0M | $0.0M | $0.0M |
| Op margin | — | — | — | — |
| Net income | -$4.5M | -$3.8M | -$1.9M | -$1.7M |
| Gross margin | — | — | — | — |
| Gross profit | — | — | — | — |
| Operating income | -$4.5M | -$3.8M | -$1.6M | -$1.2M |
Yearly (6y)
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | $0.0M | $6.4M | $0.0M | $0.0M | — |
| Op margin | — | -38.8% | — | — | — |
| Net income | -$6.0M | -$3.1M | -$17.1M | -$36.1M | — |
| Gross margin | — | — | — | — | — |
| Gross profit | — | — | — | — | — |
| Operating income | -$6.4M | -$2.5M | -$17.3M | -$34.4M | — |
Headline scan
No flags
• No distress or material-risk keywords in recent headlines (keyword scan only — not a guarantee).
News
Price (daily)
Full chart · RSI · MACD · patternsELOX · daily-9.3% over 13 sessions
Close EMA21 EMA50 EMA200
Quarterly · revenue, net income, margins
Revenue Net income Gross margin Op margin